alpha-aminopyridine has been researched along with Basal Ganglia Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Arai, H; Baba, T; Ezura, M; Funaki, Y; Furukawa, K; Furumoto, S; Harada, R; Hasegawa, T; Hiraoka, K; Ishiki, A; Iwata, R; Kikuchi, A; Kobayashi, J; Kobayashi, M; Kudo, Y; Mugikura, S; Nakashima, I; Okamura, N; Oshima, R; Sugeno, N; Takeda, A; Taki, Y; Tano, O; Tashiro, M; Watanuki, S; Yanai, K; Yoshida, S | 1 |
| Aoki, M; Arai, H; Baba, T; Ezura, M; Funaki, Y; Furukawa, K; Furumoto, S; Harada, R; Hasegawa, T; Hiraoka, K; Ishiki, A; Iwata, R; Kikuchi, A; Kobayashi, J; Kobayashi, M; Kudo, Y; Mugikura, S; Okamura, N; Oshima, R; Sugeno, N; Takeda, A; Tano, O; Tashiro, M; Watanuki, S; Yanai, K; Yoshida, S | 1 |
2 other study(ies) available for alpha-aminopyridine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Longitudinal changes in
Topics: Aged; Aminopyridines; Basal Ganglia Diseases; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Tauopathies | 2019 |
In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aminopyridines; Autoradiography; Basal Ganglia Diseases; Biomarkers; Brain; Brain Mapping; Diagnosis, Differential; Female; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; tau Proteins | 2016 |